A Robust IPO Market--even for Devices?
Anyone who stood in the packed room at this year's Chase Hambrecht & Quist meeting in San Francisco in early January for the presentation by e-commerce player Neoforma.com Inc. could hardly be surprised by the results of the company's IPO, which went out the week following, raising $91 million for the B2B supply chain manager. But as well as the Neoforma public offering did, it was, arguably, nothing compared to the IPO of Aspect Medical Systems Inc., a manufacturer of depth-of-anesthesia monitoring devices.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.